The Leukemia & Lymphoma Society | Advocacy Groups

It’s easy to think of scientific researchers as existing in a vacuum.

Nutrition is a challenge for many patients with cancer.

Cancer is one of the most expensive medical conditions to treat in the U.S.

As we observe World Cancer Day, I’m reflecting on my own family’s experience with blood cancer.

Treating patients with CAR-T cell therapy Breyanzi may change the paradigm for those with relapsed or refractory mantle cell lymphoma, an expert said.

Increased awareness and support may be one of the many ways to help decrease the impact of disparities in multiple myeloma.

An FDA committee voted that the benefits of Carvykti outweigh the risks for myeloma treatment, though concerns about secondary malignancies remain.

Menin inhibitors for patients with AML have been one of many improvements within the blood cancer space this year, Lee Greenberger of the Leukemia and Lymphoma Society told CURE®.

LLS’s Investment in Leading-Edge Research Aims to Accelerate Treatment Innovation and Expand Equitable Access to Treatments to Increase the Quality of Life and Survival Rates for All Blood Cancer Patients.

Nearly 80 and 90 percent of adults respectively don’t associate lymphoma and myeloma as types of blood cancer; LLS provides free blood cancer education and resources for all and personalized support for patients, survivors, families, and caregivers.

Why minimal residual disease testing is the "gold standard" for some patients and providers.

As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.

As part of its Speaking Out video series, CURE spoke with Dr. Lee Greenberger, chief scientific officer of the Leukemia & Lymphoma Society, about the current research in treatments.

As part of its Speaking Out video series, CURE spoke with Dr. Lee Greenberger, chief scientific officer of the Leukemia & Lymphoma Society, who discussed recent treatment advancements and FDA approvals.

As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.

As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.